uniQure N.V. (QURE) · Insider trading
What uniQure's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$22.08M
12 insiders, 90% under a plan
Net, 12 months
−$22.08M
bought less sold
Latest filing
2026-07-07
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Kapusta Matthew CDirector, CEO, Managing Director | – | $24.43M | 26 | 2026-07-02 | 531,109 |
| Kaye JackDirector | – | $2.72M | 10 | 2026-06-30 | 25,996 |
| Abi-Saab WalidChief Medical Officer | – | $2.65M | 9 | 2026-06-30 | 168,235 |
| Gut RobertDirector | – | $1.81M | 10 | 2026-06-11 | 32,259 |
| Klemt ChristianChief Financial Officer | – | $1.63M | 9 | 2026-03-04 | 226,581 |
| Balachandran MadhavanDirector | – | $889,434 | 6 | 2026-06-17 | 49,644 |
| O'Keefe KylieChief Customer & Strat Officer | – | $431,228 | 1 | 2026-06-11 | 108,864 |
| Potts JeannetteChief Legal Officer | – | $404,687 | 5 | 2026-06-15 | 133,246 |
| Jacques Rachelle SuzanneDirector | – | $84,449 | 2 | 2026-06-11 | 33,903 |
| Post Leonard eDirector | – | $84,449 | 2 | 2026-06-11 | 35,494 |
| Springhorn Jeremy P.Director | – | $84,449 | 2 | 2026-06-11 | 43,251 |
| Meek David D.Director | – | $84,449 | 2 | 2026-06-11 | 39,747 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-02 | Kapusta Matthew CDirector, CEO, Managing Director | Saleplan | 9,200 | 44.43 | $408,756 | 531,109 | Form 4 |
| 2026-07-02 | Kapusta Matthew CDirector, CEO, Managing Director | Saleplan | 4,282 | 45.43 | $194,531 | 526,827 | Form 4 |
| 2026-07-02 | Kapusta Matthew CDirector, CEO, Managing Director | Saleplan | 7,600 | 45.89 | $348,764 | 519,227 | Form 4 |
| 2026-06-30 | Kaye JackDirector | Saleplan | 4,107 | 46.49 | $190,934 | 25,996 | Form 4 |
| 2026-06-30 | Kaye JackDirector | Saleplan | 17,060 | 46.43 | $792,096 | 25,996 | Form 4 |
| 2026-06-30 | Abi-Saab WalidChief Medical Officer | Saleplan | 10,000 | 46.46 | $464,600 | 168,235 | Form 4 |
| 2026-06-30 | Abi-Saab WalidChief Medical Officer | Saleplan | 20,000 | 46.40 | $928,000 | 148,235 | Form 4 |
| 2026-06-26 | Abi-Saab WalidChief Medical Officer | Sale | 1,434 | 46.86 | $67,197 | 168,235 | Form 4 |
| 2026-06-25 | Kapusta Matthew CDirector, CEO, Managing Director | Saleplan | 28,716 | 50.02 | $1.44M | 519,227 | Form 4 |
| 2026-06-24 | Kapusta Matthew CDirector, CEO, Managing Director | Saleplan | 6,696 | 50.00 | $334,800 | 519,227 | Form 4 |
| 2026-06-18 | Kapusta Matthew CDirector, CEO, Managing Director | Saleplan | 4,656 | 50.00 | $232,800 | 558,810 | Form 4 |
| 2026-06-18 | Kapusta Matthew CDirector, CEO, Managing Director | Saleplan | 37,015 | 50.00 | $1.85M | 521,795 | Form 4 |
| 2026-06-17 | Kaye JackDirector | Saleplan | 5,295 | 42.57 | $225,408 | 25,996 | Form 4 |
| 2026-06-17 | Balachandran MadhavanDirector | Saleplan | 5,295 | 47.08 | $249,289 | 49,644 | Form 4 |
| 2026-06-17 | Balachandran MadhavanDirector | Saleplan | 4,700 | 43.66 | $205,202 | 44,944 | Form 4 |
| 2026-06-17 | Balachandran MadhavanDirector | Saleplan | 1,690 | 42.60 | $71,994 | 43,254 | Form 4 |
| 2026-06-17 | Kapusta Matthew CDirector, CEO, Managing Director | Saleplan | 23,977 | 42.61 | $1.02M | 699,262 | Form 4 |
| 2026-06-17 | Kapusta Matthew CDirector, CEO, Managing Director | Saleplan | 6,023 | 43.70 | $263,205 | 693,239 | Form 4 |
| 2026-06-17 | Kapusta Matthew CDirector, CEO, Managing Director | Saleplan | 32,581 | 45.02 | $1.47M | 660,658 | Form 4 |
| 2026-06-17 | Kapusta Matthew CDirector, CEO, Managing Director | Saleplan | 56,929 | 43.43 | $2.47M | 603,729 | Form 4 |
| 2026-06-17 | Kapusta Matthew CDirector, CEO, Managing Director | Saleplan | 33,334 | 45.01 | $1.50M | 570,395 | Form 4 |
| 2026-06-17 | Kapusta Matthew CDirector, CEO, Managing Director | Saleplan | 11,585 | 48.65 | $563,610 | 558,810 | Form 4 |
| 2026-06-15 | Potts JeannetteChief Legal Officer | Sale | 5,237 | 27.67 | $144,908 | 133,246 | Form 4 |
| 2026-06-15 | Balachandran MadhavanDirector | Saleplan | 10,000 | 27.85 | $278,500 | 43,254 | Form 4 |
| 2026-06-11 | Balachandran MadhavanDirector | Sale | 1,993 | 27.06 | $53,931 | 43,254 | Form 4 |
| 2026-06-11 | Jacques Rachelle SuzanneDirector | Sale | 1,993 | 27.06 | $53,931 | 33,903 | Form 4 |
| 2026-06-11 | Kaye JackDirector | Sale | 1,993 | 27.06 | $53,931 | 25,996 | Form 4 |
| 2026-06-11 | Post Leonard eDirector | Sale | 1,993 | 27.06 | $53,931 | 35,494 | Form 4 |
| 2026-06-11 | Springhorn Jeremy P.Director | Sale | 1,993 | 27.06 | $53,931 | 43,251 | Form 4 |
| 2026-06-11 | O'Keefe KylieChief Customer & Strat Officer | Sale | 15,936 | 27.06 | $431,228 | 108,864 | Form 4 |
| 2026-06-11 | Gut RobertDirector | Saleplan | 2,726 | 27.06 | $73,766 | 32,259 | Form 4 |
| 2026-06-11 | Meek David D.Director | Sale | 1,993 | 27.06 | $53,931 | 39,747 | Form 4 |
| 2026-06-10 | Gut RobertDirector | Saleplan | 2,645 | 26.07 | $68,955 | 32,342 | Form 4 |
| 2026-06-10 | Gut RobertDirector | Saleplan | 3,127 | 26.03 | $81,396 | 29,215 | Form 4 |
| 2026-06-10 | Gut RobertDirector | Saleplan | 1,780 | 26.05 | $46,369 | 27,435 | Form 4 |
| 2026-06-03 | Kaye JackDirector | Saleplan | 2,645 | 30.01 | $79,376 | 20,439 | Form 4 |
| 2026-05-08 | Abi-Saab WalidChief Medical Officer | Saleplan | 25,000 | 25.10 | $627,500 | 189,669 | Form 4 |
| 2026-05-08 | Abi-Saab WalidChief Medical Officer | Saleplan | 20,000 | 25.00 | $500,000 | 169,669 | Form 4 |
| 2026-03-04 | Klemt ChristianChief Financial Officer | Sale | 12,000 | 9.06 | $108,720 | 226,581 | Form 4 |
| 2026-03-04 | Potts JeannetteChief Legal Officer | Sale | 3,412 | 9.06 | $30,913 | 138,483 | Form 4 |
44 more
| 2026-03-04 | Abi-Saab WalidChief Medical Officer | Sale | 808 | 9.06 | $7,320 | 189,669 | Form 4 |
| 2026-03-04 | Kapusta Matthew CDirector, CEO, Managing Director | Sale | 14,581 | 9.06 | $132,104 | 660,658 | Form 4 |
| 2026-03-02 | Abi-Saab WalidChief Medical Officer | Sale | 1,660 | 9.95 | $16,517 | 148,777 | Form 4 |
| 2026-03-02 | Potts JeannetteChief Legal Officer | Sale | 8,578 | 9.95 | $85,351 | 106,495 | Form 4 |
| 2026-03-02 | Klemt ChristianChief Financial Officer | Sale | 12,532 | 9.95 | $124,693 | 198,981 | Form 4 |
| 2026-03-02 | Kapusta Matthew CDirector, CEO, Managing Director | Sale | 34,437 | 9.95 | $342,648 | 604,639 | Form 4 |
| 2026-02-25 | Klemt ChristianChief Financial Officer | Sale | 6,217 | 23.86 | $148,338 | 211,513 | Form 4 |
| 2026-02-25 | Kapusta Matthew CDirector, CEO, Managing Director | Sale | 12,378 | 23.86 | $295,339 | 639,076 | Form 4 |
| 2026-01-12 | Gut RobertDirector | Saleplan | 17,310 | 24.39 | $422,191 | 40,645 | Form 4 |
| 2026-01-12 | Gut RobertDirector | Saleplan | 500 | 25.03 | $12,515 | 40,145 | Form 4 |
| 2026-01-12 | Gut RobertDirector | Saleplan | 7,803 | 25.09 | $195,777 | 32,342 | Form 4 |
| 2026-01-09 | Kaye JackDirector | Saleplan | 6,390 | 27.28 | $174,319 | 20,439 | Form 4 |
| 2025-11-06 | Gut RobertDirector | Saleplan | 15,840 | 27.22 | $431,165 | 55,739 | Form 4 |
| 2025-11-06 | Gut RobertDirector | Saleplan | 15,594 | 27.30 | $425,716 | 40,145 | Form 4 |
| 2025-11-04 | Kaye JackDirector | Saleplan | 10,000 | 30.36 | $303,600 | 20,439 | Form 4 |
| 2025-11-04 | Kaye JackDirector | Saleplan | 11,000 | 30.34 | $333,740 | 20,439 | Form 4 |
| 2025-11-04 | Kaye JackDirector | Saleplan | 17,810 | 30.33 | $540,177 | 20,439 | Form 4 |
| 2025-09-26 | Klemt ChristianChief Financial Officer | Saleplan | 15,000 | 55.00 | $825,000 | 217,730 | Form 4 |
| 2025-09-24 | Klemt ChristianChief Financial Officer | Saleplan | 3,000 | 40.04 | $120,120 | 217,730 | Form 4 |
| 2025-09-24 | Kapusta Matthew CDirector, CEO, Managing Director | Saleplan | 51,316 | 39.59 | $2.03M | 826,454 | Form 4 |
| 2025-09-24 | Kapusta Matthew CDirector, CEO, Managing Director | Saleplan | 60,000 | 40.04 | $2.40M | 766,454 | Form 4 |
| 2025-09-24 | Kapusta Matthew CDirector, CEO, Managing Director | Saleplan | 49,978 | 40.68 | $2.03M | 716,476 | Form 4 |
| 2025-09-24 | Kapusta Matthew CDirector, CEO, Managing Director | Saleplan | 5,022 | 41.69 | $209,367 | 711,454 | Form 4 |
| 2025-09-24 | Kapusta Matthew CDirector, CEO, Managing Director | Saleplan | 60,000 | 45.10 | $2.71M | 651,454 | Form 4 |
| 2025-06-27 | Abi-Saab WalidChief Medical Officer | Sale | 1,466 | 13.92 | $20,407 | 150,437 | Form 4 |
| 2025-06-20 | Meek David D.Director | Sale | 2,112 | 14.45 | $30,518 | 34,190 | Form 4 |
| 2025-06-20 | Balachandran MadhavanDirector | Sale | 2,112 | 14.45 | $30,518 | 37,697 | Form 4 |
| 2025-06-20 | Gut RobertDirector | Sale | 3,336 | 14.45 | $48,205 | 56,879 | Form 4 |
| 2025-06-20 | Jacques Rachelle SuzanneDirector | Sale | 2,112 | 14.45 | $30,518 | 28,346 | Form 4 |
| 2025-06-20 | Kaye JackDirector | Sale | 2,112 | 14.45 | $30,518 | 20,439 | Form 4 |
| 2025-06-20 | Post Leonard eDirector | Sale | 2,112 | 14.45 | $30,518 | 29,937 | Form 4 |
| 2025-06-20 | Springhorn Jeremy P.Director | Sale | 2,112 | 14.45 | $30,518 | 37,694 | Form 4 |
| 2025-06-16 | Potts JeannetteChief Legal Officer | Sale | 4,670 | 15.14 | $70,704 | 115,073 | Form 4 |
| 2025-03-04 | Potts JeannetteChief Legal Officer | Sale | 7,076 | 10.29 | $72,812 | 119,743 | Form 4 |
| 2025-03-04 | Klemt ChristianChief Financial Officer | Sale | 10,438 | 10.29 | $107,407 | 217,730 | Form 4 |
| 2025-03-04 | Abi-Saab WalidChief Medical Officer | Sale | 1,350 | 10.29 | $13,891 | 151,903 | Form 4 |
| 2025-03-04 | Kapusta Matthew CDirector, CEO, Managing Director | Sale | 28,341 | 10.29 | $291,629 | 651,454 | Form 4 |
| 2025-02-27 | Klemt ChristianChief Financial Officer | Sale | 2,916 | 11.32 | $33,009 | 155,168 | Form 4 |
| 2025-02-27 | Kapusta Matthew CDirector, CEO, Managing Director | Sale | 6,717 | 11.32 | $76,036 | 580,795 | Form 4 |
| 2025-02-25 | Klemt ChristianChief Financial Officer | Sale | 14,341 | 10.70 | $153,449 | 152,372 | Form 4 |
| 2025-02-25 | Kapusta Matthew CDirector, CEO, Managing Director | Sale | 26,727 | 10.70 | $285,979 | 571,188 | Form 4 |
| 2024-12-10 | Kapusta Matthew CDirector, CEO, Managing Director | Saleplan | 100,000 | 15.03 | $1.50M | 597,915 | Form 4 |
| 2024-12-09 | Klemt ChristianChief Financial Officer | Sale | 1,796 | 7.55 | $13,560 | 166,713 | Form 4 |
| 2024-12-09 | Kapusta Matthew CDirector, CEO, Managing Director | Sale | 3,418 | 7.63 | $26,079 | 597,915 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
27 × grant or award26 × option exercise
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-02 | Kapusta Matthew CDirector, CEO, Managing Director | Option exercise M | +21,082 | 19.39 | 540,309 | Form 4 |
| 2026-06-30 | Kaye JackDirector | Option exercise M | +4,107 | 37.00 | 30,103 | Form 4 |
| 2026-06-30 | Kaye JackDirector | Option exercise M | +17,060 | 20.18 | 43,056 | Form 4 |
| 2026-06-30 | Abi-Saab WalidChief Medical Officer | Option exercise M | +10,000 | 5.59 | 178,235 | Form 4 |
| 2026-06-25 | Kapusta Matthew CDirector, CEO, Managing Director | Option exercise M | +28,716 | 31.71 | 547,943 | Form 4 |
| 2026-06-24 | Kapusta Matthew CDirector, CEO, Managing Director | Option exercise M | +4,128 | 31.71 | 525,923 | Form 4 |
| 2026-06-18 | Kapusta Matthew CDirector, CEO, Managing Director | Option exercise M | +4,656 | 31.71 | 563,466 | Form 4 |
| 2026-06-17 | Kaye JackDirector | Option exercise M | +5,295 | 31.71 | 31,291 | Form 4 |
| 2026-06-17 | Balachandran MadhavanDirector | Option exercise M | +5,295 | 31.71 | 48,549 | Form 4 |
| 2026-06-17 | Balachandran MadhavanDirector | Option exercise M | +6,390 | 19.39 | 54,939 | Form 4 |
| 2026-06-17 | Kapusta Matthew CDirector, CEO, Managing Director | Option exercise M | +62,581 | 19.39 | 723,239 | Form 4 |
| 2026-06-15 | Balachandran MadhavanDirector | Option exercise M | +10,000 | 8.49 | 53,254 | Form 4 |
| 2026-06-10 | Balachandran MadhavanDirector | Grant or award A | +7,550 | – | 45,247 | Form 4 |
| 2026-06-10 | Jacques Rachelle SuzanneDirector | Grant or award A | +7,550 | – | 35,896 | Form 4 |
| 2026-06-10 | Kaye JackDirector | Grant or award A | +7,550 | – | 27,989 | Form 4 |
| 2026-06-10 | Post Leonard eDirector | Grant or award A | +7,550 | – | 37,487 | Form 4 |
| 2026-06-10 | Springhorn Jeremy P.Director | Grant or award A | +7,550 | – | 45,244 | Form 4 |
| 2026-06-10 | Gut RobertDirector | Option exercise M | +2,645 | 16.04 | 34,987 | Form 4 |
| 2026-06-10 | Gut RobertDirector | Grant or award A | +7,550 | – | 34,985 | Form 4 |
| 2026-06-10 | Meek David D.Director | Grant or award A | +7,550 | – | 41,740 | Form 4 |
| 2026-06-03 | Kaye JackDirector | Option exercise M | +2,645 | 16.04 | 23,084 | Form 4 |
| 2026-05-08 | Abi-Saab WalidChief Medical Officer | Option exercise M | +25,000 | 5.59 | 214,669 | Form 4 |
| 2026-03-04 | O'Keefe KylieChief Customer & Strat Officer | Grant or award A | +19,800 | – | 124,800 | Form 4 |
| 2026-03-04 | Klemt ChristianChief Financial Officer | Grant or award A | +39,600 | – | 238,581 | Form 4 |
| 2026-03-04 | Potts JeannetteChief Legal Officer | Grant or award A | +35,400 | – | 141,895 | Form 4 |
| 2026-03-04 | Abi-Saab WalidChief Medical Officer | Grant or award A | +41,700 | – | 190,477 | Form 4 |
| 2026-03-04 | Kapusta Matthew CDirector, CEO, Managing Director | Grant or award A | +70,600 | – | 675,239 | Form 4 |
| 2026-01-12 | Gut RobertDirector | Option exercise M | +17,810 | 14.08 | 57,955 | Form 4 |
| 2026-01-09 | Kaye JackDirector | Option exercise M | +6,390 | 19.39 | 26,829 | Form 4 |
| 2025-11-06 | Gut RobertDirector | Option exercise M | +15,840 | 4.57 | 71,579 | Form 4 |
| 2025-11-04 | Kaye JackDirector | Option exercise M | +10,000 | 7.37 | 30,439 | Form 4 |
| 2025-11-04 | Kaye JackDirector | Option exercise M | +11,000 | 5.37 | 31,439 | Form 4 |
| 2025-11-04 | Kaye JackDirector | Option exercise M | +17,810 | 14.08 | 38,249 | Form 4 |
| 2025-09-26 | Klemt ChristianChief Financial Officer | Option exercise M | +15,000 | 5.37 | 232,730 | Form 4 |
| 2025-09-24 | Klemt ChristianChief Financial Officer | Option exercise M | +3,000 | 13.03 | 220,730 | Form 4 |
| 2025-09-24 | Kapusta Matthew CDirector, CEO, Managing Director | Option exercise M | +51,316 | 7.53 | 702,770 | Form 4 |
| 2025-09-24 | Kapusta Matthew CDirector, CEO, Managing Director | Option exercise M | +175,000 | 6.22 | 877,770 | Form 4 |
| 2025-06-11 | Meek David D.Director | Grant or award A | +7,970 | – | 36,302 | Form 4 |
| 2025-06-11 | Springhorn Jeremy P.Director | Grant or award A | +7,970 | – | 39,806 | Form 4 |
| 2025-06-11 | Balachandran MadhavanDirector | Grant or award A | +7,970 | – | 39,809 | Form 4 |
| 2025-06-11 | Gut RobertDirector | Grant or award A | +7,970 | – | 60,215 | Form 4 |
| 2025-06-11 | Jacques Rachelle SuzanneDirector | Grant or award A | +7,970 | – | 30,458 | Form 4 |
| 2025-06-11 | Kaye JackDirector | Grant or award A | +7,970 | – | 22,551 | Form 4 |
| 2025-06-11 | Post Leonard eDirector | Grant or award A | +7,970 | – | 32,049 | Form 4 |
| 2025-03-03 | Potts JeannetteChief Legal Officer | Grant or award A | +35,000 | – | 126,819 | Form 4 |
| 2025-03-03 | Klemt ChristianChief Financial Officer | Grant or award A | +73,000 | – | 228,168 | Form 4 |
| 2025-03-03 | Abi-Saab WalidChief Medical Officer | Grant or award A | +38,000 | – | 153,253 | Form 4 |
| 2025-03-03 | Kapusta Matthew CDirector, CEO, Managing Director | Grant or award A | +99,000 | – | 679,795 | Form 4 |
| 2025-02-26 | Klemt ChristianChief Financial Officer | Grant or award A | +5,712 | – | 158,084 | Form 4 |
| 2025-02-26 | Kapusta Matthew CDirector, CEO, Managing Director | Grant or award A | +16,324 | – | 587,512 | Form 4 |
| 2024-12-10 | Kapusta Matthew CDirector, CEO, Managing Director | Option exercise M | +100,000 | 14.71 | 697,915 | Form 4 |
| 2024-12-08 | Klemt ChristianChief Financial Officer | Grant or award A | +3,672 | – | 168,509 | Form 4 |
| 2024-12-08 | Kapusta Matthew CDirector, CEO, Managing Director | Grant or award A | +10,494 | – | 601,333 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.